Home
Technical GuideAnalytical MethodsPublished Aug 24, 2026

Mass Spectrometry in Impurity Identification — LC-MS Approach

By the PharmaCountry team

How LC-MS is used to identify unknown impurities flagged by a related substances method.

When MS Identification Is Needed

Mass spectrometric identification becomes necessary when a related substances or stability-indicating method detects a chromatographic peak above a reporting or identification threshold that cannot be attributed to any known, previously characterized impurity or degradation product, since regulatory expectations generally require identification of any impurity approaching or exceeding the applicable identification threshold before it can be adequately toxicologically qualified or otherwise assessed for genuine patient safety relevance. Identification work should be prioritized based on the unknown peak's level relative to relevant thresholds and any observed trend suggesting the peak may continue increasing over the product's shelf life.

LC-MS Workflow

The identification workflow typically begins with obtaining an accurate mass measurement of the unknown compound, from which candidate molecular formulas can be proposed, followed by tandem mass spectrometry fragmentation analysis to generate structural fragment information that, combined with knowledge of the parent drug's own structure and likely degradation or synthesis-related impurity pathways, allows a proposed structure to be developed for the unknown impurity. This workflow benefits enormously from chemical logic informed by the parent compound's known structure and reactivity, since a proposed structure consistent with a plausible degradation or synthesis pathway from the known parent compound carries considerably more credibility than one lacking any clear, chemically sensible mechanistic connection.

Structure Elucidation

Beyond mass spectrometry alone, structure elucidation often benefits from complementary techniques including nuclear magnetic resonance spectroscopy, which provides detailed structural information mass spectrometry alone cannot, particularly for distinguishing between structurally similar candidate structures that might produce very similar or even identical mass spectral fragmentation patterns. The choice of which complementary techniques to employ depends on the amount of isolated or synthesized impurity material available and the specific structural ambiguity remaining after initial mass spectrometric characterization.

Confirming the Result

A proposed structure should ultimately be confirmed, most definitively through independent synthesis of the proposed structure followed by direct chromatographic and spectral comparison against the original unknown impurity, demonstrating the synthesized reference material genuinely matches the original unknown in retention time, mass spectrum, and, where performed, other spectroscopic characteristics. A proposed structure based on mass spectrometric and chemical logic alone, without this independent confirmatory synthesis and comparison, represents a plausible hypothesis rather than a definitively confirmed identification, a distinction that matters for how confidently the identification can be relied upon for subsequent toxicological qualification.

Isolation Approaches When Synthesis Is Impractical

Where independent synthesis of the proposed impurity structure is impractical, isolation of sufficient quantity of the actual impurity directly from stressed or degraded sample material, using preparative chromatographic techniques, provides an alternative path to obtaining material for confirmatory characterization and, potentially, for use as an actual reference standard for the impurity going forward. Isolation approaches require careful technique to avoid introducing artifacts or further degradation during the isolation process itself, which could produce a misleading characterization of a compound that does not actually accurately represent the impurity as it exists in the original sample.

Connecting Identification to Toxicological Qualification

Once an impurity's structure is confirmed, the identification feeds directly into toxicological qualification assessment under ICH Q3B or Q3A frameworks, which evaluates whether the impurity's structure raises any specific safety concern, such as structural alerts suggesting potential genotoxicity, warranting either specific toxicological study or, where the structure and level support it, qualification based on existing safety data and established, applicable thresholds. This connection underscores why accurate, confirmed structural identification matters considerably beyond mere analytical curiosity, since the entire subsequent safety qualification pathway depends directly on having correctly and confidently identified the actual impurity structure.

Documentation of the Identification Process

Impurity identification work should be documented thoroughly, capturing the analytical data supporting the proposed structure, the reasoning connecting that data to the final proposed structure, and any confirmatory work performed, providing both current regulatory submission support and a valuable reference for any future situation where the same or a structurally related impurity is encountered again in the same or a related product.

Building Internal Impurity Reference Libraries

Facilities and companies working with a portfolio of related products benefit from building an internal reference library of previously identified impurities, including their structures, typical formation conditions, and analytical characteristics, since a newly detected unknown impurity in one product may well match a previously characterized impurity from a structurally related product, allowing much faster identification than starting the full identification workflow completely from scratch on every occasion.